| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2018 | FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression. | Hsu, CY; Chang, GC; Chen, YJ; Hsu, YC; Hsiao, YJ; Su, KY; Chen, HY ; Lin, CY; Chen, JS; Chen, YJ; Hong, QS; Ku, WH; Wu, CY; Ho, BC; Chiang, CC; Yang, PC; Yu, SL | Clinical cancer research : an official journal of the American Association for Cancer Research 24(4), 916-926 | | | |
| 2015 | HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma. | Wang, CC; Su, KY; Chen, HY; Chang, SY; Shen, CF; Hsieh, CH; Hong, QS; Chiang, CC; Chang, GC; Yu, SL; Chen, JJ | PloS one 10(4), e0124191 | | | |
| 2015 | Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan. | Hsu, KH; Ho, CC; Hsia, TC; Tseng, JS; Su, KY; Wu, MF; Chiu, KL; Yang, TY; Chen, KC; Ooi, H; Wu, TC; Chen, HJ; Chen, HY; Chang, CS; Hsu, CP; Hsia, JY; Chuang, CY; Lin, CH; Chen, JJ; Chen, KY; Liao, WY; Shih, JY; Yu, SL; Yu, CJ; Yang, PC; Chang, GC | PloS one 10(3), e0120852 | | | |
| 2016 | Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice | Su, KY; Kao, JT; Ho, BC; Chen, HY ; Chang, GC; Ho, CC; Yu, SL | Scientific reports 6, 30944 | | | |
| 2016 | JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer. | Chang, WH; Ho, BC; Hsiao, YJ; Chen, JS; Yeh, CH; Chen, HY ; Chang, GC; Su, KY; Yu, SL | PloS one 11(3), e0150355 | | | |
| 2016 | Molecular gene signature and prognosis of non-small cell lung cancer | Huang, P; Cheng, CL; Chang, YH; Liu, CH; Hsu, YC; Chen, JS; Chang, GC; Ho, BC; Su, KY; Chen, HY ; Yu, SL | Oncotarget 7(32), 51898-51907 | | | |
| 2012 | Pre-treatment EGFR T790M Mutation Predicts Shorter EGFR-TKI Response Duration in Non-small-cell Lung Cancer Patients | Su, KY; Chen, HY; Li, KC ; Kuo, ML; Yang, James CH; Chan, WK; Ho, BC; Chang, GC; Shih, JY; Yu, SL; Yang, PC | JOURNAL OF CLINICAL ONCOLOGY doi: 10.1200/JCO.2011.38.3224 | | | |
| 2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang, YH; Hsu, KH; Tseng, JS; Chen, KC; Su, KY; Chen, HY ; Chang, CS; Chen, JJ; Yu, SL; Chen, HW; Yang, TY; Chang, GC | Journal of thoracic disease 8(1), 86-92 | | | |
| 2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma. | Tseng, JS; Yang, TY; Chen, KC; Hsu, KH; Yu, CJ; Liao, WY; Tsai, CR; Tsai, MH; Yu, SL; Su, KY; Chen, JJ; Chen, HY; Chang, GC | OncoTargets and therapy 7, 799-805 | | | |
| 2015 | R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability | Chen, HY; Yu, SL; Ho, BC; Su, KY; Hsu, YC; Chang, CS; Li, YC; Yang, SY; Hsu, PY; Ho, H; Chang, YH; Chen, CY; Yang, HI; Hsu, CP; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Hsia, JY; Chuang, CY; Yuan, S; Lee, MH; Liu, CH; Wu, GI; Hsiung, CA; Chen, YM; Wang, CL; Huang, MS; Yu, CJ; Chen, KY; Tsai, YH; Su, WC; Chen, HW; Chen, JJ; Chen, CJ; Chang, GC; Yang, PC; Li, KC | JOURNAL OF CLINICAL ONCOLOGY 33(20), 2303-2310 | | | |
| 2014 | Shisa3 is associated with prolonged survival through promoting beta-catenin degradation in lung cancer. | Chen, CC; Chen, HY ; Su, KY; Hong, QS; Yan, BS; Chen, CH; Pan, SH; Chang, YL; Wang, CJ; Hung, PF; Yuan, S; Chang, GC; Chen, JJ; Yang, PC; Yang, YC; Yu, SL | American journal of respiratory and critical care medicine 190(4), 433-44 | | | |
| 2016 | Small Molecule T315 Promotes Casitas B-Lineage Lymphoma-Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation. | Huang, KY; Kao, SH; Wang, WL; Chen, CY; Hsiao, TH; Salunke, SB; Chen, JJ; Su, KY; Yang, SC; Hong, TM; Chen, CS; Yang, PC | American journal of respiratory and critical care medicine 193(7), 753-766 | | | |
| 2016 | SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma | Hsiao, YJ; Su, KY; Hsu, YC; Chang, GC; Chen, JS; Chen, HY ; Hong, QS; Hsu, SC; Kang, PH; Hsu, CY; Ho, BC; Yang, TH; Wang, CY; Jou, YS; Yang, PC; Yu, SL | Oncotarget 7, 44417-44429 | | | |
